Medtronic has launched a new continuous glucose monitoring (CGM) system which allows for more accurate and simple diabetes management than previous devices.
The iPro2 Professional CGM system has been launched in 49 countries after receiving CE Mark accreditation and consists of a glucose sensor and a small data recorder.
Medtronic states that the device is more straightforward to use than other systems, requiring no computer setup and minimal patient interaction.
It provides detailed reports on blood glucose levels, detecting high and low glucose fluctuations which are often passed over by traditional A1C tests but which can nevertheless lead to health complications.
Dr Francine Kaufman, chief medical officer and vice-president of global medical, clinical and health affairs at Medtronic's diabetes business, said: "iPro2 Professional CGM is quick to implement and provides reports that physicians can use to educate patients on the therapy and lifestyle changes they can make to improve their health."
Earlier this month, Medtronic published data from a clinical study which illustrated the advantages its deep brain stimulation technology can deliver for sufferers of Parkinson's disease.
No comments:
Post a Comment